Literature DB >> 6473643

Caffeine: relationship to human anxiety, plasma MHPG and cortisol.

T W Uhde, J P Boulenger, D C Jimerson, R M Post.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6473643

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  10 in total

1.  Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX.

Authors:  G Griebel; M Saffroy-Spittler; R Misslin; D Remmy; E Vogel; J J Bourguignon
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Caffeine consumption among eating disorder patients: epidemiology, motivations, and potential of abuse.

Authors:  A Burgalassi; C E Ramacciotti; M Bianchi; E Coli; L Polese; E Bondi; G Massimetti; L Dell'osso
Journal:  Eat Weight Disord       Date:  2009-12       Impact factor: 4.652

Review 3.  The Impact of Caffeine on the Behavioral Effects of Ethanol Related to Abuse and Addiction: A Review of Animal Studies.

Authors:  Laura López-Cruz; John D Salamone; Mercè Correa
Journal:  J Caffeine Res       Date:  2013-03

4.  The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors.

Authors:  M El Yacoubi; C Ledent; J F Ménard; M Parmentier; J Costentin; J M Vaugeois
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  Acute dose-effect relationships of caffeine and mental performance, EEG, cardiovascular and subjective parameters.

Authors:  M Hasenfratz; K Bättig
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

6.  The use of a plus-maze to measure anxiety in the mouse.

Authors:  R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 7.  Do initial responses to drugs predict future use or abuse?

Authors:  Harriet de Wit; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2012-04-21       Impact factor: 8.989

8.  Anxiolytic activity of adenosine receptor activation in mice.

Authors:  N Jain; N Kemp; O Adeyemo; P Buchanan; T W Stone
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

9.  Modelling anxiety in humans for drug development.

Authors:  Martin Siepmann; Peter Joraschky
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

10.  Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.

Authors:  M Albus; T P Zahn; A Breier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.